Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 23, 2014, Pages 8595-8600

  Triviai, Ioanna ^a,b   Ziegler, Marion ^a   Bergholz, Ulla ^a   Oler, Andrew J ^c   Stübig, Thomas ^b   Prassolov, Vladimir ^d   Fehse, Boris ^b   Kozak, Christine A ^c   Kröger, Nicolaus ^b   Stocking, Carol ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ECOTROPIC MURINE LEUKEMIA VIRUS; ENDOGENOUS RETROVIRUS; LEUKEMIA VIRUS; MOUSE; MYELOID METAPLASIA; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; TUMOR XENOGRAFT;

AGED; ANIMALS; BLOTTING, SOUTHERN; ENDOGENOUS RETROVIRUSES; FEMALE; HUMANS; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LEUKEMIA VIRUS, MURINE; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, MYELOID, ACUTE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MICE, TRANSGENIC; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PRIMARY MYELOFIBROSIS; PROVIRUSES; TRANSPLANTATION, HETEROLOGOUS; VIRUS INTEGRATION; VIRUS REPLICATION; YOUNG ADULT;

EID: 84902197944     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1401215111     Document Type: Article

References (46)

1. Campbell PJ, Green AR (2006) The myeloproliferative disorders. N Engl J Med 355(23):2452-2466. (Pubitemid 44903749)
2. Jamieson CH, Barroga CF, Vainchenker WP (2008) Miscreant myeloproliferative disorder stem cells. Leukemia 22(11):2011-2019.
3. Sloma I, Jiang X, Eaves AC, Eaves CJ (2010) Insights into the stem cells of chronic myeloid leukemia. Leukemia 24(11):1823-1833.
4. Valent P, et al. (2013) Heterogeneity of neoplastic stem cells: Theoretical, functional, and clinical implications. Cancer Res 73(3):1037-1045.
5. Jamieson CH, et al. (2004) Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351(7):657-667. (Pubitemid 39063268)
6. Vainchenker W, Delhommeau F, Constantinescu SN, Bernard OA (2011) New mutations and pathogenesis of myeloproliferative neoplasms. Blood 118(7):1723-1735.
7. Levine RL, Pardanani A, Tefferi A, Gilliland DG (2007) Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer 7(9):673-683. (Pubitemid 47327415)
8. Barbui T, et al.; European LeukemiaNet (2011) Philadelphia-negative classical myeloproliferative neoplasms: Critical concepts and management recommendations from European LeukemiaNet. J Clin Oncol 29(6):761-770.
9. Dick JE (2008) Stem cell concepts renew cancer research. Blood 112(13):4793-4807.
10. Shultz LD, Ishikawa F, Greiner DL (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7(2):118-130. (Pubitemid 46174859)
11. Coffin JM, Stoye JP, Frankel WN (1989) Genetics of endogenous murine leukemia viruses. Ann N Y Acad Sci 567:39-49. (Pubitemid 19213349)
12. Prochazka M, Gaskins HR, Shultz LD, Leiter EH (1992) The nonobese diabetic scid mouse: Model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 89(8):3290-3294.
13. Stocking C, Kozak CA (2008) Murine endogenous retroviruses. Cell Mol Life Sci 65(21):3383-3398.
14. Stoye JP (2012) Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat Rev Microbiol 10(6):395-406.
15. Jenkins NA, Copeland NG, Taylor BA, Lee BK (1982) Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes of Mus musculus. J Virol 43(1):26-36. (Pubitemid 12084879)
16. Jenkins NA, Copeland NG (1985) High frequency germline acquisition of ecotropic MuLV proviruses in SWR/J-RF/J hybrid mice. Cell 43(3 Pt 2):811-819.
17. Suzuki T, et al. (2002) New genes involved in cancer identified by retroviral tagging. Nat Genet 32(1):166-174. (Pubitemid 34977213)
18. Sanz-Ramos M, Stoye JP (2013) Capsid-binding retrovirus restriction factors: Discovery, restriction specificity and implications for the development of novel therapeutics. J Gen Virol 94(Pt 12):2587-2598.
19. Kim T, Mudry RA, Jr., Rexrode CA, 2nd, Pathak VK (1996) Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication. J Virol 70(11):7594-7602. (Pubitemid 26339064)
20. Stevens A, et al. (2004) Retroviral capsid determinants of Fv1 NB and NR tropism. J Virol 78(18):9592-9598. (Pubitemid 39187076)
21. Rosenke K, et al. (2012) Profound amplification of pathogenic murine polytropic retrovirus release from coinfected cells. J Virol 86(13):7241-7248.
22. Métais JY, Dunbar CE (2008) The MDS1-EVI1 gene complex as a retrovirus integration site: Impact on behavior of hematopoietic cells and implications for gene therapy. Mol Ther 16(3):439-449.
23. Lataillade J-J, et al.; French INSERM and the European EUMNET Networks on Myelofibrosis (2008) Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence. Blood 112(8):3026-3035.
24. Old LJ, Boyse EA, Lilly F (1963) Formation of cytoxic antibody against leukemias induced by Friend virus. Cancer Res 23:1063-1068.
25. Nair S, et al. (2011) Distinct roles of CD4+ T cell subpopulations in retroviral immunity: Lessons from the Friend virus mouse model. Retrovirology 8:76.
26. Young GR, et al. (2012) Resurrection of endogenous retroviruses in antibody-deficient mice. Nature 491(7426):774-778.
27. Yu P, et al. (2012) Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors. Immunity 37(5):867-879.
28. Wolf D, Goff SP (2008) Host restriction factors blocking retroviral replication. Annu Rev Genet 42:143-163.
29. Stavrou S, et al. (2013) Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex. Proc Natl Acad Sci USA 110(22):9078-9083.
30. Stoye JP, Moroni C, Coffin JM (1991) Virological events leading to spontaneous AKR thymomas. J Virol 65(3):1273-1285.
31. Hoggan MD, O'Neill RR, Kozak CA (1986) Nonecotropic murine leukemia viruses in BALB/c and NFS/N mice: Characterization of the BALB/c Bxv-1 provirus and the single NFS endogenous xenotrope. J Virol 60(3):980-986. (Pubitemid 17179273)
32. Baliji S, Liu Q, Kozak CA (2010) Common inbred strains of the laboratory mouse that are susceptible to infection by mouse xenotropic gammaretroviruses and the human-derived retrovirus XMRV. J Virol 84(24):12841-12849.
33. Cao X, et al. (1995) Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2(3):223-238.
34. Ney PA, D'Andrea AD (2000) Friend erythroleukemia revisited. Blood 96(12):3675-3680.
35. Tefferi A, et al. (2011) Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: A comprehensive cytokine profiling study. J Clin Oncol 29(10):1356-1363.
36. Elliot MA, Yoon S-Y, Kao P, Li C-Y, Tefferi A (2002) Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia. Eur J Haematol 68(3):175-179. (Pubitemid 34620607)
37. de Graaf CA, Metcalf D (2011) Thrombopoietin and hematopoietic stem cells. Cell Cycle 10(10):1582-1589.
38. Schuettpelz LG, Link DC (2013) Regulation of hematopoietic stem cell activity by inflammation. Front Immunol 4:204.
39. Tefferi A (2005) Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol 23(33):8520-8530.
40. Greaves M (2010) Cancer stem cells: Back to Darwin? Semin Cancer Biol 20(2):65-70.
41. Theocharides A, et al. (2007) Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation. Blood 110(1):375-379. (Pubitemid 47026857)
42. Campbell PJ, et al. (2006) Mutation of JAK2 in the myeloproliferative disorders: Timing, clonality studies, cytogenetic associations, and role in leukemic transformation. Blood 108(10):3548-3555.
43. Delhommeau F, et al. (2009) Mutation in TET2 in myeloid cancers. N Engl J Med 360(22):2289-2301.
44. Beer PA, et al. (2010) Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm. Blood 115(14):2891-2900.
45. Paprotka T, et al. (2011) Recombinant origin of the retrovirus XMRV. Science 333(6038):97-101.
46. Serreze DV, et al. (1995) Emv30null NOD-scid mice. An improved host for adoptive transfer of autoimmune diabetes and growth of human lymphohematopoietic cells. Diabetes 44(12):1392-1398.